Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06046833 · ClinicalTrials.gov registry record · NA

Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes

A NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1, sponsored by Samita Garg.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06046833 is a NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1 that is actively recruiting participants, run by Samita Garg. The registered enrollment target is 50 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06046833, a NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1, is actively recruiting participants, sponsored by Samita Garg.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

A pilot study to evaluate and compare glucose metrics using a real-time continuous glucose monitor (FreeStyle Libre 3 sensor) between patients with diabetes and gastroparesis and those with diabetes without gastroparesis.

Conditions Studied

Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 1 Gastroparesis With Diabetes Mellitus

Interventions

  • DEVICE FreeStyle Libre 3 continuous glucose monitoring sensor
  • OTHER Nutritional drink

Study Locations (1)

Ohio

  • Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-01-08
Est. Completion 2026-03
Phase NA

Sponsor

Samita Garg

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06046833

The ClinicalTrials.gov registry entry for NCT06046833 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The listed sponsor is Samita Garg, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which FreeStyle Libre 3 continuous glucose monitoring sensor is the first listed.

NCT06046833 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06046833 about?

NCT06046833 is a clinical study titled "Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes". A pilot study to evaluate and compare glucose metrics using a real-time continuous glucose monitor (FreeStyle Libre 3 sensor) between patients with diabetes and gastroparesis and those with diabetes without gastroparesis.

What is the current status of trial NCT06046833?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-01-08. Estimated completion is 2026-03.

What conditions does trial NCT06046833 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Gastroparesis With Diabetes Mellitus.

What interventions are being tested in trial NCT06046833?

The interventions under investigation include: FreeStyle Libre 3 continuous glucose monitoring sensor (DEVICE), Nutritional drink (OTHER).

Who is sponsoring clinical trial NCT06046833?

This trial is sponsored by Samita Garg, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06046833 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus, Type 2

All registered trials for this condition

Diabetes Mellitus, Type 1

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.